Skip to main content
Clinical Trials/IRCT20090901002394N44
IRCT20090901002394N44
Recruiting
Phase 3

Effect of probiotic supplementation on cognitive function and BDNF in patients with type 2 diabetes

Iran University of Medical Sciences0 sites84 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
84
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Willing to participate and signing informed consent
  • Having type 2 diabetes based on medical records
  • At least 2 years history of type 2 diabetes
  • No change in the type and dose of medication taken 8 weeks before the intervention
  • Not eating probiotic\-containing foods for the past 4 weeks

Exclusion Criteria

  • Cancer, severe liver and kidney disorders, heart failure and surgery and other endocrine disorders
  • Pregnancy and lactation and hormone\-sensitive conditions
  • Use of liver, anticoagulant, and platelet\-degrading drugs
  • Use of antidepressants and other drugs that affect the nerves
  • Insulin injection
  • Contraceptive use
  • Recent dietary supplements (no case if calcium \- vitamin D and group B supplements are routinely consumed for the past 6 months)
  • Use of antibiotics for the past 1 month
  • Tobacco, drugs and alcohol
  • weight loss diet and weight changes over 5% in the last 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials